IMAGE-GUIDED SURGERY

Preclinical Protocols For Image-Guided Surgery

Coordinatore	ACADEMISCH ZIEKENHUIS LEIDEN    more  Organization address address: Albinusdreef 2 city: LEIDEN postcode: 2333 ZA contact info Titolo: Mr. Nome: Jacobus Cognome: De Graaf Email: send email Telefono: 31715265150 Fax: 31715266941
Nazionalità Coordinatore	Netherlands [NL]
Totale costo	243˙847 €
EC contributo	243˙847 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2013-IEF
Funding Scheme	MC-IEF
Anno di inizio	2014
Periodo (anno-mese-giorno)	2014-04-01   -   2016-03-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	ACADEMISCH ZIEKENHUIS LEIDEN  Organization address address: Albinusdreef 2 city: LEIDEN postcode: 2333 ZA contact info Titolo: Mr. Nome: Jacobus Cognome: De Graaf Email: send email Telefono: 31715265150 Fax: 31715266941	NL (LEIDEN)	coordinator	243˙847.80

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'This project aims to build upon current developments in molecular imaging by developing a camera system and a tumour margin marker to be used in a first-in-human-trail. Molecular in vivo imaging is a fertile area which harbours a mix of expertise, state-of-art equipment and many different disciplines and inter-sector work environments. It is hoped that in the future it will be implemented as the fourth clinical modality in conjunction with the three already established clinical imaging techniques of magnetic resonance imaging (MRI), x-ray computed tomography (CT) and positron emission tomography (PET). The proposed project seeks to demonstrate that ZW800-1 (a novel zwitterionic Near Infra-Red Fluorescence (NIRF) dye), when conjugated onto a cRGD peptide, can be used to identify a minimum tumour margin distance during intra-operative image-guided surgery. These will be optimized to be used with clinical hand-held camera systems ArtemisTM, mini-FLARETM and MSOTTM . The overall aim is to aid the surgeon to visibly demarcate tumour from healthy tissue so that a complete image-guided surgical solution to cancer can be of benefit to patients and the healthcare system.'